Data Scientist, Insights Strategy & Design

Location: Basel, Switzerland
Job Type: Full-Time
Employer: Novartis International AG
In your role as Data Scientist with the Insights Strategy & Design group you will primarily be responsible for data science and advanced analytics activities, including explorative applications of machine learning, deep learning and artificial intelligence that are a component of projects directed by the Insights Strategy & Design group, and often sponsored by the Development Committee of Novartis.

You will drive the creation and execution of the data science section of project plans for one or more advanced analytics projects under the strategic guidance of the Head Insights Strategy & Design. You will further contribute to the overall project strategy.

Your role is to understand complex and critical business problems from Country/Regional/Global business functions, formulate integrated analytical approach to mine data sources, employ statistical methods, machine learning algorithms, deep learning and artificial intelligence to discover actionable insights, automate process for reducing effort and time for repeated use.

You will have the agility to be able to work across various business domains (commercial, NTO, GDD,NIBR, NBS). Able to use business presentations, smart visualization tools and contextual story-telling to translate findings back to business users with a clear impact. No direct team management

Your responsibilities will include

  • Provide solutions for a variety of business applications including but not limited to: Customer Segmentation & Targeting, Event Prediction, Propensity Modelling, Churn Modelling, Customer Lifetime Value Estimation, Forecasting, Recommender Systems, Modelling Response to Incentives, Marketing Mix Optimization, Price Optimization
  • Develop automation for repeatedly refreshing analysis and generating insights
  • Collaborate with globally dispersed internal stakeholders and cross-functional teams to solve critical business problems, drive operational efficiencies, and deliver successfully on high visibility strategic initiatives
  • Understand life science data sources including sales, contracting, promotions, social media, patient claims and Real World Evidence
  • Make right choices from a breadth of tools, data sources and analytical techniques to answer a wide range of critical business questions
  • Articulate solutions/recommendations to business users. Present analytical content concisely and effectively to non-technical audiences and influence non-analytical business leaders to drive major strategic decisions basis analytical inputs
  • Project manages critical initiatives: plan proactively, anticipate and actively manage change, set stakeholder expectations as required, identify operational risks and independently drive issues to resolution, balance multiple priorities and minimize surprise escalations
  • Ensure exemplary communication with all stakeholders including senior business leaders across Novartis
  • Act as an evangelist and catalyst for innovation in Data Science and AI
  • Independently identify research articles and reproduce/apply methodology to Novartis business problems

Minimum requirements

  • Masters in a quantitative discipline (e.g. Applied Mathematics, Computer Science, bioinformatics, epidemiology and Statistics. PhD preferred
  • Fluent English (oral and written)
  • 5+ years of relevant experience in Data Science

Apply for this job

Post your job offer now to start hiring the best digital health talent! For further information, please contact us.

Most Popular Now

AI Helps Physicians Better Assess the Ef…

In a small but multi-institutional study, an artificial intelligence (AI)-based system improved providers' assessments of whether patients with bladder cancer had complete response to chemotherapy before a radical cystectomy (bladder...

Smartwatches and Fitness Bands Reveal In…

A new digital health study by researchers at Scripps Research shows how data from wearable sensors, such as smartwatches and fitness bands, can track a person’s physiological response to the...

AI may Detect Earliest Signs of Pancreat…

An artificial intelligence (AI) tool developed by Cedars-Sinai investigators accurately predicted who would develop pancreatic cancer based on what their CT scan images looked like years prior to being diagnosed...

Open Call U4H-2022-PJ2: Call for Proposa…

The Ukraine crisis has an unprecedented impact on the mental health of the displaced people in the EU coming from Ukraine. The conflict and experiences of people in war zones...

AI Reduces Miss Rate of Precancerous Pol…

Artificial intelligence reduced by twofold the rate at which precancerous polyps were missed in colorectal cancer screening, reported a team of international researchers led by Mayo Clinic. The study is...

Medical Valley EMN & Volitan Global …

The two healthcare innovation experts Medical Valley EMN and Volitan Global strengthen their existing inbound- and outbound activities through a strategic partnership. The aim is to offer companies access to...

DMEA - Connecting Digital Health Opens w…

26 - 28 April 2022, Berlin, Germany. What plans does the new federal government have concerning the digital transformation of the healthcare sector? What are the initial experiences of doctors regarding...

AI can Predict Probability of COVID-19 v…

Testing shortages, long waits for results, and an over-taxed health care system have made headlines throughout the COVID-19 pandemic. These issues can be further exacerbated in small or rural communities...

Using AI to Detect Cancer from Patient D…

A new way of using artificial intelligence to predict cancer from patient data without putting personal information at risk has been developed by a team including University of Leeds medical...

Oulu University Hospital Expands Partner…

Siemens Healthineers and Oulu University Hospital in Finland have entered a strategic partnership for the next ten years, adding to an existing radiotherapy collaboration to jointly expand and modernize the...

Positive Conclusion to DMEA - Connecting…

26 - 28 April 2022, Berlin, Germany. After three days DMEA, Europe's leading digital health event, came to a successful conclusion - with around 11,000 visitors, more than 500 exhibitors and...

AI-Enabled ECGs may Identify Patients at…

Atrial fibrillation, the most common cardiac rhythm abnormality, has been linked to one-third of ischemic strokes, the most common type of stroke. But atrial fibrillation is underdiagnosed, partly because many...